Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

Vrenken H, Battaglini M, de Vos ML, Nagtegaal GJ, Teixeira BCA, Seitzinger A, Jack D, Sormani MP, Uitdehaag BMJ, Versteeg A, Comi G, Kappos L, De Stefano N, Barkhof F.

Open source

DOI
10.1007/s00415-022-11554-5
Published
2023-02-01
Container
J Neurol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00415-022-11554-5,
  title = {Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.},
  author = {Vrenken H and  Battaglini M and  de Vos ML and  Nagtegaal GJ and  Teixeira BCA and  Seitzinger A and  Jack D and  Sormani MP and  Uitdehaag BMJ and  Versteeg A and  Comi G and  Kappos L and  De Stefano N and  Barkhof F.},
  year = {2023},
  journal = {J Neurol},
  doi = {10.1007/s00415-022-11554-5},
  url = {https://doi.org/10.1007/s00415-022-11554-5}
}

RIS

TY  - JOUR
TI  - Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.
AU  - Vrenken H
AU  -  Battaglini M
AU  -  de Vos ML
AU  -  Nagtegaal GJ
AU  -  Teixeira BCA
AU  -  Seitzinger A
AU  -  Jack D
AU  -  Sormani MP
AU  -  Uitdehaag BMJ
AU  -  Versteeg A
AU  -  Comi G
AU  -  Kappos L
AU  -  De Stefano N
AU  -  Barkhof F.
PY  - 2023
JO  - J Neurol
DO  - 10.1007/s00415-022-11554-5
UR  - https://doi.org/10.1007/s00415-022-11554-5
ER  - 

APA

H, V., M, B., ML, D. V., GJ, N., BCA, T., A, S., D, J., MP, S., BMJ, U., A, V., G, C., L, K., N, D. S., & F., B. (2023). Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.. J Neurol. https://doi.org/10.1007/s00415-022-11554-5

Source records